BSc PhD
Chief Scientific Officer, Director
Dr Agersborg is director of Virxsys Corporation, a gene therapy corporation. He was formerly President of Wyeth-Ayerst Research. During his distinguished 45 years in the pharmaceutical industry, companies under his direction had more than 50 new drug applications approved in the US, countless marketing applications were approved outside the US and innumerable INDs were accepted.
Dr Agersborg contributes broad international pharmaceutical development experience at the highest level to the company. Since the change of company management in November 2005 Dr Agersborg has served as Chief Scientific Officer. His experience as a toxicologist and his understanding of regulatory requirements have been fundamental in the repositioning of the company.
